Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease
N/A
N/A
Both
Pilonidal Sinus
Trial Information
Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease
In addition, the study will evaluate the credibility and reproducibility of results within
other surgeons trained to perform the procedure. Data collection will focus on
post-operative wound failure, infection ratwes, analgesic requirements, time lost from work
or school, wound care requirements, and 6 month recurrence rates. These outcomes will be
compared to outcomes using conventional pilonidal surgical intervention using published
data.
Inclusion Criteria:
- Any patient with pilonidal diseas
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
wound failure, time lost from work or school, analgesic requirements, recurrence rates
Outcome Time Frame:
6 months
Principal Investigator
James J Matino, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Surgical Group,PC
Authority:
United States: Institutional Review Board
Study ID:
Pilonidal/Cymetra
NCT ID:
NCT00493493
Start Date:
January 2007
Completion Date:
June 2008
Related Keywords:
- Pilonidal Sinus
- Cymetra
- Pilonidal Sinus
Name | Location |
|---|---|
| St Francis Hospital | Hartford, Connecticut 06105 |
